| Literature DB >> 33199895 |
Julia S Brunner1,2, Andrea Vogel1,2, Omar Sharif3,4, Gernot Schabbauer5,6, Alexander Lercher7, Michael Caldera7,8, Ana Korosec9, Marlene Pühringer1,2, Melanie Hofmann1,2, Alexander Hajto1,2, Markus Kieler1,2, Lucia Quemada Garrido1,2, Martina Kerndl1,2, Mario Kuttke1,2, Ildiko Mesteri10, Maria W Górna11, Marta Kulik11, Paulina M Dominiak11, Amanda E Brandon12,13, Emma Estevez14, Casey L Egan14,15, Florian Gruber16, Martina Schweiger17, Jörg Menche7,8, Andreas Bergthaler7, Thomas Weichhart18, Kristaps Klavins7,19, Mark A Febbraio14,15.
Abstract
Adipose tissue macrophages (ATMs) display tremendous heterogeneity depending on signals in their local microenvironment and contribute to the pathogenesis of obesity. The phosphoinositide 3-kinase (PI3K) signalling pathway, antagonized by the phosphatase and tensin homologue (PTEN), is important for metabolic responses to obesity. We hypothesized that fluctuations in macrophage-intrinsic PI3K activity via PTEN could alter the trajectory of metabolic disease by driving distinct ATM populations. Using mice harbouring macrophage-specific PTEN deletion or bone marrow chimeras carrying additional PTEN copies, we demonstrate that sustained PI3K activity in macrophages preserves metabolic health in obesity by preventing lipotoxicity. Myeloid PI3K signalling promotes a beneficial ATM population characterized by lipid uptake, catabolism and high expression of the scavenger macrophage receptor with collagenous structure (MARCO). Dual MARCO and myeloid PTEN deficiencies prevent the generation of lipid-buffering ATMs, reversing the beneficial actions of elevated myeloid PI3K activity in metabolic disease. Thus, macrophage-intrinsic PI3K signalling boosts metabolic health by driving ATM programmes associated with MARCO-dependent lipid uptake.Entities:
Mesh:
Substances:
Year: 2020 PMID: 33199895 DOI: 10.1038/s42255-020-00311-5
Source DB: PubMed Journal: Nat Metab ISSN: 2522-5812